Business Wire National BioTech News
- Oragenics Issues Letter to Shareholders
- NeuPath Provides Strategic Update, Announces Board and Executive Changes
- IMV Provides an Update on The VITALIZE Trial
- Perimeter Medical Imaging AI Announces Commercial Placement of Perimeter S-Series OCT within National Healthcare Provider System
- FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
- VBI Vaccines Announces Initiation of Phase 1 Study of Multivalent Coronavirus Vaccine Candidate, VBI-2901
- Rapid Dose Therapeutics to Participate in the Venture Mentoring Services Program in Partnership with Maryland Tech Council and Canada’s Trade Commissioner Service
- Merck to Hold Third-Quarter 2022 Sales and Earnings Conference Call October 27
- Ventus Therapeutics Enters Exclusive Development and License Agreement with Novo Nordisk for NLRP3 Inhibitor Program
- Entos Pharmaceuticals Passes Significant Enrollment Milestone in Phase 2 Clinical Trial of its COVID-19 DNA Vaccine
RECENT TWEETS
Presenters from @GranvilleBiomed, @ABKBiomedical, Breathe BioMedical & @BioSciencePEI will all be chatting #MedTech at Entrevestor Live on Oct 20th. You can attend in-person or watch the livestream online.
https://t.co/SvlDKrxyde https://t.co/QR7O2sqJFZ
https://t.co/SvlDKrxyde https://t.co/QR7O2sqJFZ
We're thrilled to announce Sean Awalt as our new CEO!
"I am honoured to have the opportunity to grow BioNova’s ecosystem, where together we will enable life-changing innovations to reach markets faster for stronger economic growth and social impact.”
https://t.co/zoWlrISuki https://t.co/BRUdjJsVK0
"I am honoured to have the opportunity to grow BioNova’s ecosystem, where together we will enable life-changing innovations to reach markets faster for stronger economic growth and social impact.”
https://t.co/zoWlrISuki https://t.co/BRUdjJsVK0
